Portfolio company
LubaLabs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops 3D microscopy platforms for label-free measuring of mechanical properties in living cells and tissues to support disease modelling and drug discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
LUMICKS
This company develops single-molecule and cell avidity analysis instruments for academic researchers and pharmaceutical companies to study biological mechanisms and develop life-saving therapies.
Optics11 Life
This company develops fibre-optic nanoindentation and muscle contractility instruments for researchers in mechanobiology, drug development, and regenerative medicine.
BiomimX
BiomimX develops organs-on-chip platforms that provide mechanical stimulation to 3D microtissues for drug and medical device testing by pharmaceutical and biotechnology companies.
MYLeukaemia
This company develops a bone-marrow-on-a-chip platform for functional precision oncology to test blood cancer drug efficacy for pharmaceutical companies and clinical researchers.
Lumi
This company develops a web-based platform that uses computer vision to automate experiment monitoring and data analysis for scientists and laboratories.
Cubase Bio
This company develops optics-free DNA microscopy kits for three-dimensional spatial transcriptomics to support drug discovery and disease research for pharmaceutical and academic organisations.
IVIM Technology
This company develops intravital microscopy platforms and preclinical imaging services for researchers in immunology, neuroscience, and drug development to visualize live cells in organisms.
CellSense
This company manufactures Brillouin microscope systems for mechanobiological research applications in fields such as biomedicine, tissue engineering and pharmacology.
